Dr. Jason Bacharach (center) was the first doctor in the Western United States to implant the Glaukos iStent (the first MIGS (micro-invasive glaucoma surgical device) to treat intraocular pressure, which is currently the smallest medical device ever cleared for use in the U.S. by the FDA.
Pictured in-between our industry partners from Glaukos Corp. are: Angela Lewis, CCRC Clinical Research Dept. Director, Jason Bacharach, MD NBEA Medical Director, Principle Investigator & Terry Hannis COA, ASC Manager.
Our Research Activities and Industry Affiliations
Physicians provide an ideal resource for valuable recommendations on how to improve the safety and efficacy of existing medications and devices and are often offered ongoing consulting opportunities to furnish expert technical assistance and feedback to companies in the development and refinement of those improvements.
In short, physician expertise, feedback, and experience are critical to ongoing advances and innovations in medical technology.
When a biomedical company wants to introduce new advancements in technology to the US market an official FDA (Food and Drug Administration) clinical trial is required. North Bay Eye Associates is proud of the fact that our clinical research irector and expert ocular surgeon, Dr. Jason Bacharach, has been involved in research for over twenty years and the principal investigator in over 120 Phase I-IV clinical trials since 1993 when our clinical research center was established.
Dr. Bacharach is often selected to collaborate with leaders from the pharmaceutical and medical device industry to design and conduct various stages of clinical studies, which have focused on increasing the effectiveness of Glaucoma Management, Ocular Hypertension, Cataract Surgery, Dry Eye, and Blepharitis, as well as, other ocular diseases. In addition, he is frequently invited to consult with industry and to present the results of the studies, conducted at NBEA’s research facility, to other healthcare providers throughout the Country.
Clinical Research has become an integral part of our practice over the years and we believe this close association with industry has and will continue to afford us the opportunity to offer the latest advances in treatment and technology and provide the highest quality of eye care to our patients throughout Sonoma County. Some of the companies we work closely with are:
● Aerie ● Alcon Research ● Allergan ● Amakem ● Bausch & Lomb ● Ciba ● Elli Lilly ● Forsight ● Glaukos ● Icon ● Inspire ● Insite ● Ista ● Kendle ● Merck ● Novagali ● Oculos ● ONO ● Optovue ● Pfizer ● PPD ● PRN ● Rigel ● Santen ● Sarcode ● Solx ● Syreon
Our state of the art Clinical Research Center, located in Petaluma, CA, is a dedicated facility with two full time certified clinical research coordinators, one assistant and several technicians. We provide a relaxing waiting room, private exam rooms, locked drug storage and document cabinets, laboratory with two centrifuges, refrigerator/freezer, and a private monitoring office with wireless internet access and use of printer/copier/fax. We take great pride in making our patients and industry guests as comfortable and welcome as possible.
North Bay Eye Associates, Inc. has been an established Sonoma County Eye Care Group since 1993. In addition to our research center we have four clinic locations in Sonoma County as well as a dedicated out-patient surgical facility in Santa Rosa. The group consists of six ophthalmologists, two optometrists, with four dedicated optical departments.
Our Research Director
Dr. Jason Bacharach is the Medical Director of North Bay Eye Associates and Principle Investigator for the clinical studies conducted at North Bay Eye’s Research Facility in Petaluma. He is certified with the California Medical Board, American Board of Ophthalmology and an active member of the American Glaucoma Society. His Academic affiliations include being the Associate Clinical Professor of Ophthalmology and Chief of Glaucoma Clinics at California Pacific Medical Center in San Francisco, CA. Dr. Bacharach is a well -respected physician not only in our community but throughout the Country, who takes great pride in offering his patients with the highest quality of care and working with the newest innovations in ophthalmic treatment.